tiprankstipranks
Advertisement
Advertisement

PCMED72 Stock Latest News

Mediar Therapeutics Enters R&D Collaboration On Fibro-Inflammatory Antibody Therapies
Private CompaniesMediar Therapeutics Enters R&D Collaboration On Fibro-Inflammatory Antibody Therapies
10h ago
MED72
Mediar Therapeutics Strikes Option-Backed Fibrosis Alliance With Ono, Advances Antibody Pipeline
PremiumPrivate Companies
Mediar Therapeutics Strikes Option-Backed Fibrosis Alliance With Ono, Advances Antibody Pipeline
11h ago
MED72
Employee Wellness Initiatives Highlight Mediar Therapeutics’ Internal Culture
PremiumPrivate Companies
Employee Wellness Initiatives Highlight Mediar Therapeutics’ Internal Culture
3d ago
MED72
Mediar Therapeutics – Weekly Recap
PremiumPrivate Companies
Mediar Therapeutics – Weekly Recap
12d ago
MED72
Community Engagement Underscores Mediar Therapeutics’ Focus on Fibrosis Research
PremiumPrivate Companies
Community Engagement Underscores Mediar Therapeutics’ Focus on Fibrosis Research
16d ago
MED72
Mediar Therapeutics Highlights Progress on Phase 2 Fibrosis Program at Scleroderma Conference
PremiumPrivate CompaniesMediar Therapeutics Highlights Progress on Phase 2 Fibrosis Program at Scleroderma Conference
20d ago
MED72
Community Engagement Underscores Mediar Therapeutics’ Focus on Kidney Disease
Premium
Private Companies
Community Engagement Underscores Mediar Therapeutics’ Focus on Kidney Disease
21d ago
MED72
Mediar Therapeutics Strengthens Scientific Leadership Through Internal Promotions
Premium
Private Companies
Mediar Therapeutics Strengthens Scientific Leadership Through Internal Promotions
29d ago
MED72
Mediar Therapeutics Advances Kidney Fibrosis Portfolio With First-in-Human MTX-439 Trial
PremiumPrivate CompaniesMediar Therapeutics Advances Kidney Fibrosis Portfolio With First-in-Human MTX-439 Trial
1M ago
MED72

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >